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Abstract
Single-nucleotide polymorphisms in the first intron of the ubiquitously expressed FTO gene are associated with obesity.
Although the physiological functions of FTO remain unclear, food intake is often altered when Fto expression levels are
manipulated. Furthermore, deletion of FTO from neurones alone has a similar effect on food intake to deletion of FTO in all
tissues. These results indicate that FTO expression in the brain is particularly important. Considerable focus has been placed
on the dynamic regulation of Fto mRNA expression in the hypothalamus after short-term (16–48 hour) fasting, but results
have been controversial. There are no studies that quantify FTO protein levels across the brain, and assess its alteration
following short-term fasting. Using immunohistochemistry, we found that FTO protein is widely expressed in mouse brain,
and present in the majority of neurones. Using quantitative Western blotting and RT-qPCR we show that FTO protein and
mRNA levels in the hypothalamus, cerebellum and rostral brain are relatively uniform, and levels in the brain are higher than
in skeletal muscles of the lower limbs. Fasting for 18 hours does not alter the expression pattern, or levels, of FTO protein
and mRNA. We further show that the majority of POMC neurones, which are critically involved in food intake regulation, also
express FTO, but that the percentage of FTO-positive POMC neurones is not altered by fasting. In summary, we find no
evidence that Fto/FTO expression is regulated by short-term (18-hour) fasting. Thus, it is unlikely that the hunger and
increased post-fasting food intake caused by such food deprivation is driven by alterations in Fto/FTO expression. The
widespread expression of FTO in neurones also suggests that physiological studies of this protein should not be limited to
the hypothalamus.
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Introduction
Obesity is a major public health issue. It predisposes to
numerous diseases, including heart disease, type 2 diabetes and
cancer, and it imposes a significant economic burden on Western
societies. By 2030 it is estimated that over 50% of the world
population will be overweight or obese [1]. Monogenic causes of
obesity result in dramatic phenotypes but are extremely rare.
Genes associated with more common, less severe forms of obesity
have recently begun to be revealed by genome wide association
studies. In this way, single nucleotide polymorphisms (SNPs) in the
first intron of the fat mass and obesity-associated (FTO) gene were
found to be associated with obesity in numerous human
populations [2,3,4]. Approximately 16% of individuals of
European descent are homozygous for the at-risk (A) allele, and
have an ,1.67-fold increased risk of obesity, weighing on average
,3 kg more than those with the T allele (rs9939609. In most
studies that directly measured food intake, individuals possessing at
least one copy of the A allele ate more than those with the T allele
[5,6,7]. These results are in agreement with those from a large
questionnaire study [8]. However, in another study where food
intake was measured, FTO genotype was not associated with total
energy intake, but rather with altered food preference; individuals
with the A allele consumed a greater proportion of calories from
fat [9]. These results suggest that FTO may affect body weight by
influencing food intake and dietary composition.
Studies in mice generally support this hypothesis. First, enhanced
expression of Fto leads to hyperphagia, increased fat mass, and a
higherbodyweight[10].Second,geneticdeletionofFto,oraloss-of-
function Fto mutation, lead to reduced body weight. Paradoxically,
mice lacking Fto are relatively hyperphagic despite their lower body
weight, although this may be a secondary consequence of their
growth defect and failure to thrive [11]. Indeed, mice harbouring a
loss-of-function mutation in Fto show no alteration in feeding
behaviour [12]. Taken together, these data demonstrate that
alterations in global expression levels or function of Fto in mice are
positively and reliably correlated with changes in body weight.
However, while global overexpression of Fto increases food intake,
loss of Fto function has variable effects on energy consumption.
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have different effects to changes in global expression. For example,
when Fto mRNA levels are directly manipulated in the
hypothalamic arcuate nucleus of rats by adenoviral infection of
Fto or by small interfering RNA (siRNA) against Fto, food intake is
also altered [13]. However, in this study, increased Fto expression
in the arcuate nucleus was associated with decreased food intake and
a consequent reduction in body weight. Thus, Fto overexpression
specifically in the arcuate nucleus has the opposite effect to global
overexpression of the protein.
Appetite and food intake are controlled by the brain, specifically
by neurones within the hypothalamus although other brain areas
also contribute to feeding behaviour [14]. Thus FTO is predicted
to influence neuronal activity, although whether it does it directly
(via changes in neuronal FTO expression/activity) or indirectly via
hormones or messengers released from FTO-regulated peripheral
cells is still unclear. In an attempt to distinguish between these two
possibilities several studies have focused on the expression of Fto in
the brain, and searched for differences in the fed and fasted state,
primarily in the hypothalamus.
The effects of food intake on Fto expression have, however, been
controversial. An increase (in rat hypothalamus [15]), decrease (in
mouse arcuate nucleus [16]) or no significant change (in mouse
hypothalamus [17]) in Fto mRNA levels has variously been
reported in response to fasting for 40–48 hours. However, fasting
mice for .24 hours, may result in pathophysiological responses as
it leads to significant weight loss, depletion of hepatic glycogen
stores [18,19,20] and loss of ,60% of fat stores [21]. Fasting mice
for longer than 48 hours leads to elevation of glucocorticoid levels
and increased mortality [22,23]. Only one study has examined the
effects of short-term (16 hr) fasting [24]: this was reported to lead
to upregulation of hypothalamic Fto mRNA levels.
With one exception [25], where long-term energy restriction
was shown to reduce FTO expression in hypothalamus and
brainstem, previous studies have focused on Fto mRNA levels
rather than protein levels and most have been confined to the
hypothalamus. However, as high Fto mRNA levels have been
identified in many brain regions [15], it is important to determine
if expression is differentially regulated by fasting in different brain
regions. Protein levels are also required as they may not be fully
representative of mRNA levels, at least in the short term, if FTO
protein turnover is slow.
In this paper, therefore, we investigate changes in the expression
of Fto mRNA and FTO protein in various brain regions in
response to an overnight (18 hr) fast. Similar studies were carried
out on two types of skeletal muscles that are largely composed of
fast twitch fibres [26,27]. Our results show that both protein and
mRNA levels of Fto are higher in brain than in muscle but do not
differ between various brain regions or between the individual
muscles. Using immunohistochemistry we further show that Fto is
expressed in the majority of neurones, where it is confined to the
nucleus. We found no difference in protein or mRNA levels, in
neuronal distribution, or in nuclear localisation of Fto after an
18 hour fast.
Results
FTO protein is widely expressed across the brain
Immunohistochemical experiments on brains of free-fed mice
revealed that FTO protein is not limited to specific brain regions
but is expressed relatively uniformly throughout the brain,
including the hypothalamus (Figure 1A), hippocampus and
neocortex (Figure 1B), and the cerebellum (Figures 1C and 1D).
Brain regions with high neuronal density, such as the granule cell
layers of the hippocampus and cerebellum, were especially
conspicuous.
Western blots of total protein isolated from the cerebellum,
hypothalamus and rostral brain of free-fed mice confirmed that
FTO protein levels were relatively uniform across the brain
(Figures 2A and 2B). Although FTO protein levels in the
cerebellum were somewhat enriched, there were no significant
differences between any of the three brain regions (Figure 2B).
Likewise, FTO protein levels in the gastrocnemius and extensor
digitorum longus muscles were not significantly different from one
another (Figures 2A and 2B). However, there was significantly less
FTO protein in skeletal muscle than in brain. Pairwise
comparisons between each brain and muscle sample revealed that
FTO levels in extensor digitorum longus muscle were significantly
lower than those in rostral brain (p,0.05), cerebellum (p,0.001)
and hypothalamus (p,0.05). Likewise, FTO levels in gastrocne-
mius were significantly lower than those in the cerebellum
(p,0.001). Although FTO levels in gastrocnemius were not lower
than those in the rostral brain and hypothalamus, the differences
neared significance (p=0.06 and p=0.07, respectively). When
protein levels from the three different brain regions of free-fed
mice were pooled, and compared to pooled values from skeletal
muscle, muscle FTO protein levels were significantly lower than
those in brain (p,0.001, Figure 2B).
These results are in excellent agreement with those found for Fto
mRNA expression using quantitative PCR (Figure 2C). Fto mRNA
levels in the three brain regions of free-fed animals were not
significantly different. Similarly, transcript levels were not
significantly different between the two different types of muscle.
However, the pairwise comparison between each brain and muscle
sample revealed that transcript expression is very significantly less
in muscle (p,0.001 in each case).
FTO is expressed in neurones
To analyse the expression pattern of FTO within specific brain
regions in detail, and determine if FTO is confined to neurones,
we turned to confocal fluorescence microscopy and double-
labelled cells with primary antibodies against FTO ([12]; Figure
S1) and NeuN. NeuN is a nuclear protein that labels most
neurones, although not cerebellar Purkinje cells [28].
The vast majority (.90%) of cells in the hypothalamus and
neocortex that labelled with NeuN were also labelled with FTO
(Figures 3A and 3B). This analysis could not be carried out on the
images from the cerebellum and hippocampus as the cell density
was too high to allow accurate quantification. Nevertheless it is
evident that many cells were double labelled (Figures 3C and 3D).
Due to the highly organised laminar structure of the cerebellum, it
was also possible to identify some cells that were labelled with anti-
FTO, but not anti-NeuN (Figure 3C, arrowed). At least some of
these cells, such as the Purkinje cells, are neurones that are not
labelled with NeuN; nevertheless, it remains possible that some of
these cells are not neuronal. FTO-positive but NeuN-negative cells
were also seen occasionally in other brain regions, but they were
always very few.
Consistent with previous reports [11,16,29], FTO expression
was restricted to the cell nucleus, being excluded from the
cytoplasm and nucleolus (Figure 3).
Effects of fasting on FTO mRNA and protein expression
Fasting did not significantly change FTO protein (Figure 2B) or
mRNA (Figure 2C) levels in any of five tissues that were tested.
Interestingly, when Fto and reference gene mRNA levels were
analysed together in geNorm, Fto itself was one of the most stable
genes found in both free-fed and fasted animal tissues (File S1).
Expression of FTO Protein in the Brain
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protein across the brain on fasting (compare Figure 1 with Figure
S3). The neuronal localisation of FTO also did not obviously
change (compare Figure 3 with Figure S4), with ,90% of cortical
and hypothalamic neurones still expressing FTO. Furthermore,
FTO did not alter its subcellular distribution on fasting, and
remained confined to the nucleus (Figure S4).
FTO in POMC neurones
POMC neurones are crucial for regulation of food intake and
energy homeostasis [14] and activation of POMC-expressing
neurones in the arcuate nucleus of the hypothalamus reduces food
intake [30]. We therefore next examined the effect of fasting on
FTO protein levels in POMC neurones. We used POMC-Z/EG
mice, which express eGFP in POMC-expressing neurones [31],
which enabled us to identify POMC neurones by their endogenous
GFP fluorescence. We used an anti-FTO antibody and a Texas-
red secondary antibody to identify FTO-expressing cells, and
DAPI to detect all cells. The number of FTO-positive POMC
neurones in the arcuate nucleus of free-fed and fasted mice was
counted while blinded to the status of the animals.
Figure 4A shows that FTO is expressed in the nucleus of the
majority of POMC neurones. In the free-fed state, approximately
75% of POMC-expressing neurones were labelled with the anti-
FTO antibody (Figure 4B). The proportion of FTO-positive POMC
cells was not significantly altered after 18 hours of fasting. There
were also a significant number of cells that expressed FTO but not
GFP, indicating that cells in the arcuate nucleus other than POMC
neuronesexpressFTO.Thisisconsistentwithapreviousreport[11].
Discussion
Our results demonstrate by immunohistochemistry, quantitative
Western blot, and Reverse Transcription quantitative PCR
experiments that Fto is widely expressed, at relatively uniform
levels, across the brain. This is in agreement with the widespread
distribution of Fto mRNA seen in in situ hybridisation and RT-
qPCR experiments [15,16,32].
FTO was found almost exclusively in neurones. In double-
labelling immunohistochemistry, more than 90% of NeuN-positive
neurones in the neocortex and hypothalamus were also positive for
FTO. However, the NeuN antibody does not label all neurones
Figure 1. FTO protein is widely expressed in the brain of free-fed mice. Representative images of brain sections from a free-fed mouse (7-
week-old female C57BL/6J) probed for FTO protein and stained with DAB (which appears black). (A) hypothalamus, (B) hippocampus and neocortex,
(C, D) cerebellum. 3V, 3rd ventricle. CA1 and CA3, subfields of hippocampus. DG, dentate gyrus. I–VI, layers of neocortex. Horizontal black bars
indicate 200 mm.
doi:10.1371/journal.pone.0027968.g001
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clearly not labelled in our experiments. Thus it is possible that an
even greater percentage of FTO-positive cells in the neocortex and
hypothalamus may be neurones. Interestingly, only ,75% of GFP-
positive (POMC-expressing) neurones in the arcuate nucleus of
POMC-Z/EG mice were FTO-positive. This suggests that at least
some POMC neurones do not express FTO (we make the
assumption that GFP is only expressed in POMC neurones). Thus,
it appears that the relative percentage of FTO-expressing neurones
varies between 75% and 90%, depending on the brain region.
We observed that both Fto mRNA and protein levels were
significantly higher in brain than in skeletal muscle. In contrast,
previous reports have suggested Fto mRNA in skeletal muscle is
similar, or greater, than in brain [15,25]. However, neither of
these studies stated which muscles had been analysed, so it is
possible that Fto levels are higher in skeletal muscles other than
gastrocnemius and extensor digitorum longus. However, the
physiological relevance of these observations is debatable because
Fto abundance does not necessarily indicate functional impor-
tance.
Figure 2. FTO protein and mRNA levels are not altered after ,18 hours of fasting. (A) Representative Western blots of total proteins from
free-fed and fasted male C57BL/6J mouse tissues probed for murine FTO and heat shock 70 kDa protein 8 (Hspa8, loading control). Lanes show
rostral brain (1), cerebellum (2), hypothalamus (3), gastrocnemius muscle (4) and extensor digitorum longus muscle (5). (B) Relative levels of FTO
protein, normalised to Hspa8, in tissues from free-fed (grey bars, n=8) and fasted (white bars, n=8) 8-week-old C57BL/6J mice. RB, rostral brain; Cb,
cerebellum; Hyp, hypothalamus; Gast, gastrocnemius muscle; EDL, Extensor Digitorum Longus muscle. Data are mean6SEM. There were no
significant differences between individual brain samples (or between individual muscle samples) based on nutritional status (two-way ANOVA). In
free-fed mice, the pooled mean of the three brain samples was significantly higher than the pooled mean of the two muscle samples (one-way
ANOVA). ***, p,0.001. (C) RT-qPCR quantification of FTO transcript levels in tissues from free-fed (grey bars, n=8) and fasted (white bars, n=8) 7-
week-old C57BL/6J wild-type mice. RB, rostral brain; Cb, cerebellum; Hyp, hypothalamus; Gast, gastrocnemius muscle; EDL, Extensor Digitorum
Longus muscle. Data are mean6SEM. There were no significant differences between individual brain samples (or between individual muscle samples)
based on nutritional status (two-way ANOVAs). In free-fed mice, the level of FTO mRNA in each brain region was higher than in either of the two
types of muscle (one-way ANOVA with post-hoc pairwise comparisons). ***, p,0.001 for any brain sample versus any muscle sample.
doi:10.1371/journal.pone.0027968.g002
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Considerable emphasis in previous studies has been placed on
the nutritional regulation of Fto expression in the hypothalamus.
However, in our experiments there were no significant differences
in Fto transcript or protein levels either in the hypothalamus or any
other brain region in response to an overnight fast.
Fto mRNA expression levels in free-fed and acutely fasted
rodent hypothalamus have been quantified in several previous
studies [15,16,17,24]. It is possible that the significant differences
reported for some studies were due to the severity of fasting that
was imposed on the animals as pathophysiological processes
produced by extended fasting may have resulted in secondary
changes in Fto expression. The only study that imposed a short
period of fasting of similar duration (16 hours) to our study
(18 hours) reported that hypothalamic Fto mRNA levels were
upregulated [24]. There are a few differences between our studies
and those of Olszewski and colleagues [24]. They used male
C57BL/6J mice whereas we used both male and female C57BL/
6J mice: however, we found no differences based on sex. They
used 12-week-old animals, whereas we used 7-week-old mice; and
they also fed their mice a different chow to ours. Thus, it is possible
that dietary and/or age-related factors could account for the
difference in our results. Furthermore, as Olszewski and colleagues
did not measure protein levels, it is unclear whether FTO function
will be altered in their mice.
In summary, our results clearly demonstrate that neither Fto
mRNA nor FTO protein expression in brain or muscle are
affected by overnight fasting. Thus, FTO is unlikely to regulate
food intake in response to short-term lack of food via alterations in
expression levels in these tissues. Rather, our data suggest that
compensatory feeding on reintroduction of food is likely to be
mediated (i) via changes in the activity of FTO in muscle/brain, or
(ii) by changes in gene expression in other tissues, or (iii) it involves
an entirely different mechanism. Whether FTO activity is affected
by nutritional status is unclear. FTO is an AlkB-like 2-
oxoglutarate–dependent nucleic acid demethylase that has been
shown to demethylate 3-methylthymine in single-stranded DNA
[16] and N6-methyladenosine in nuclear RNA [29]. FTO has also
been postulated to serve as a regulator of gene transcription [34].
The activity of many transcription factors is regulated by shuttling
them into and out of the nucleus; our data further suggest that
FTO does not act in this way to modulate food intake, as its
nuclear localisation is unaffected by an 18 hr fast. Finally, while
our results do not support the idea that changes in neuronal Fto
Figure 3. FTO is widely expressed in neurones of the hypothalamus, neocortex, cerebellum and hippocampus. Representative
confocal images of sections from the hypothalamus (A), neocortex (B), cerebellum (C) and hippocampus (D) of fasted 7-week-old male C57BL6/mice.
Sections were probed for FTO protein (red) and Neuronal Nuclear protein (NeuN, green). DAPI was used to stain all nuclei (blue). Note that the FTO
antibody labelled cell nuclei but was absent from the nucleolus and cytoplasm. Cells that label for FTO but not NeuN antibodies are indicated by
white triangles. Images are representative of 5 mice.
doi:10.1371/journal.pone.0027968.g003
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remains possible that it is involved in the response to small, long-
term changes in food supply [25].
Materials and Methods
Ethics statement
All experiments were conducted in accordance with the UK
Animals (Scientific Procedures) Act (1986) and UK Home Office
regulations. The work was performed under certificate of
designation number 30/2306 and project licence 30/2668
following approval by the University of Oxford Departments of
Physiology, Anatomy & Genetics and Experimental Psychology
Joint Departmental Ethics Review Committee.
Animals
C57BL/6J mice were obtained from an in-house colony.
Transgenic POMC-Z/EG mice were congenic on a C57BL/6J
background. Mice were housed in same-sex littermate groups of
2–8 and maintained in a temperature and humidity controlled
room on a 12 hr light-dark cycle (lights on at 7am), with ad libitum
access to water at all times. Except when otherwise stated, regular
Figure 4. The proportion of POMC cells expressing FTO is not altered by fasting. (A) Representative confocal images of hypothalamic brain
sections from free-fed (upper panels) and fasted (lower panels) 7-week-old male POMC-Z/EG mice. POMC neurones were identified by GFP expression
(green) and are indicated by white triangles. Sections were also probed with anti-FTO antibody (red) and nuclei were stained with DAPI (blue). Images
are representative of 5 mice in each case. (B) Percentage of POMC cells expressing FTO in free-fed (grey bar, n=5) and fasted (white bar, n=5) 7-
week-old POMC-Z/EG mice. Data are mean6SEM. There was no significant difference in the percentage of FTO-positive POMC cells based on
nutritional status (two-way ANOVA).
doi:10.1371/journal.pone.0027968.g004
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(both control and experimental animals) were singly housed for 4
days before fasting, to accustom them to the new environment. All
experiments were carried out on 7–8 week old animals. Male and
female mice were used. As there were no significant differences
based on sex, and no interactions between sex and feeding status,
in any of the analyses data from male and female animals are
shown pooled in all figures.
Immunohistochemistry
Mice were terminally anaesthetised by intraperitoneal injection
of sodium pentobarbital and perfused intracardially with phos-
phate-buffered saline (PBS) for ,2 min followed by 4% parafor-
maldehyde in 0.1 M phosphate buffer pH 7.4 (PB) for 5 min. The
whole brain was removed from the skull and postfixed in 4%
paraformaldehyde PB at 4uC for at least 24 hours. Brains were
cryoprotected prior to sectioning on a freezing microtome (Leica
SM2000R) by immersion in 30% sucrose in PB at 4uC for 18–
42 hr. 40–50 mm sections were cut, and rinsed in 0.3% Triton
X100 PBS (PBS-Triton) at room temperature
DAB-stained immunohistochemistry. Sections were
processed according to the ABC method (Vector Labs). They
were treated with 10 ml methanol containing 100 ml hydrogen
peroxide (30% W/V; Sigma), blocked for 1 hr at room
temperature in PBS-Triton with 3% goat serum, and then
incubated with FTO antibody ([12]; Figure S1) in PBS-Triton
plus 1% goat serum for 24–60 hrs at 4uC. They were then rinsed
with PBS, incubated with biotinylated anti-rabbit IgG antibody
(Vector Labs BA-1000, 1:200 dilution) for 1.5 hr at room
temperature in PBS-Triton with 3% goat serum, and then
treated with the Vectastain Elite ABC kit (Vector Labs, PK6100)
for 1–2 hrs at room temperature. Colour was developed with a
diaminobenzidine (DAB) kit with metal enhancer (Sigmafast
D0426, Sigma). Some sections from each brain were processed
identically, but the primary antibody was omitted from the first
incubation step. Representative images of these no-primary-
antibody control brain sections are shown in Figure S2.
Rinsed sections were mounted on double-subbed slides, left to
air-dry overnight, then dehydrated and cleared in ethanol and
xylene, and mounted with DePeX (VWR International). Slides
were viewed with a Leica DMRB microscope fitted with Zeiss
objectives and images captured using a Leica DFC500 camera.
Fluorescence immunohistochemistry. Sections were
blocked for 1–1.5 hr at room temperature in PBS-Triton
containing 5% bovine serum albumin (BSA, Sigma) and 5%
goat serum (Sigma). Sections were then incubated with FTO ([12];
Figure S1) and Alexa-488-conjugated NeuN antibodies (Millipore,
MAB377X), or with FTO antibody alone (POMC-Z/EG mice) in
PBS-Triton with 5% BSA, 5% goat serum for 1 hr at room
temperature, and then transferred to 4uC for 18–36 hrs.
For FTO identification, sections were incubated for 1 hr at time
at room temperature with biotinylated anti-rabbit IgG (Vector
Labs BA-1000, 1:200 dilution) followed by Texas-Red Avidin D
(Vector Labs, A-2006, 1:100 dilution), then Biotinylated Anti-
Avidin D (Vector Labs, BA-0300, 1:100 dilution) and finally
Texas-Red Avidin D again. Sections were rinsed with PBS
between each antibody incubation. NeuN fluorescence was
increased by probing with an anti-mouse IgG secondary antibody,
conjugated to Alexa 488 (Invitrogen A11001). Sections were
subsequently incubated for 20 min in PBS with 2 ug/ml DAPI
(Sigma, D9542-5MG), to label cell nuclei, washed 3 times in PBS,
and mounted on double-subbed slides in Vectashield hardset
mounting medium (Vector Labs, H-1400 or H-1500).
Slides were viewed an LSM 510 Meta confocal microscope
(Zeiss) and a Plan-Apochromat 63x/1.4NA oil objective (Zeiss).
GFP and Alex488 were excited using the 488 nm line of an Argon
laser and emitted light was collected between 512 and 565 nm in
the Meta channel of the confocal system. Texas Red was excited
using the 543 nm line of an HeNe laser and emitted light collected
between 597 and 629 nm. DAPI was excited in the two-photon
mode with the 740 nm line of a Chameleon laser and emitted light
detected between 437 and 480 nm.
For quantification of FTO-positive POMC-expressing cells at
least 5 images were acquired for each mouse. The number of cells
positive for both FTO (red nuclei) and GFP was expressed as a
percentage of the total number of GFP-expressing (POMC)
neurones. Quantification was carried out blinded to the feeding
status of the mice.
Western Blotting
Mice were killed by cervical dislocation at ,10am, and tissues
rapidly dissected, snap frozen in liquid nitrogen, ground into a
powder and suspended in ice-cold RIPA lysis buffer containing
150 mM NaCl, 1% Nonidet P40, 0.5% Sodium Deoxycholate,
0.1% Sodium Dodecyl Sulphate (SDS), 50 mM Tris, protease
inhibitors (G-Biosciences Protecease-50 EDTA free), pH 7.4 with
HCl and 10 units of Benzonase (Novagen) to remove nucleotides,
for 15 minutes. Non-soluble material was pelleted at 20,000 g for
20 min at 4uC. The supernatant was removed and protein
concentrations quantified using the Bio-Rad DC Protein assay.
Protein samples were stored at 280uC.
For Western blotting, 35–50 mg of total protein were run on 4–
12% Bis-Tris SDS-PAGE gels (NuPAGE Novex, Invitrogen),
together with Novex Sharp Pre-stained protein standards
(Invitrogen), and transferred to PVDF membranes. Membranes
were blocked for approximately 18 hr at 4uC with 5% skimmed
milk in 0.1% Tween20 tris-buffered saline (TBST, Sigma) and
probed for 1 hr at room temperature with primary antibodies to
HSPA8 (Abcam, ab19136) and FTO [12]. HSPA8 was used as the
loading control as the Hspa8 transcript was the most stably
expressed reference gene found in RT-qPCR experiments. Blots
were then rinsed and probed with horseradish peroxidase
conjugated secondary antibody (HRP-anti-rabbit IgG for FTO,
GE Healthcare, NA934; HRP-anti-mouse IgG for Hspa8, GE
Healthcare, NA931) for 1 hr. Blots were rinsed and bands
visualised with enhanced chemiluminescence reagent (SuperSignal
West Pico, Pierce) and X-ray film.
Protein density was quantified using the gel analysis function of
ImageJ software (National Institutes of Health, USA; [35]) accord-
ing to the method described here (http://lukemiller.org/index.php/
2010/11/analyzing-gels-and-western-blots-with-image-j/). Brief-
ly, HSPA8 protein bands were quantified and converted into
relative values, such that the sample with the highest abundance
of HSPA8 had a value of 1. The same was done for FTO protein
bands. The relative values of FTO were divided by the relative
values of HSPA8 to give the relative, normalized quantity of FTO
for that sample. The results for each pair of mice were analysed
separately.
RT-qPCR experiments
Free-fed and fasted mice were killed by cervical dislocation at
,10am, and ‘rostral brain’, cerebellum, hypothalamus, gastroc-
nemius muscle, and extensor digitorum longus muscle rapidly
dissected. ‘Rostral brain’ included all brain regions rostral of
Bregma +1.10 mm, corresponding to regions ‘I’ and ‘II’ from
Fredriksson et al, 2008 [15]. Samples were immediately immersed
Expression of FTO Protein in the Brain
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Tissues were then stored at 280uC until ready to process.
Total RNA was extracted, following the manufacturer’s
instructions, from 30 mg of thawed tissue using a rotor-stator
homogeniser and an RNeasy Mini Kit (brain) or RNeasy fibrous
tissue kit (muscle) (Qiagen). All samples were treated with an on-
column DNase digestion step to remove traces of genomic DNA.
The concentration of purified total RNA was measured in
triplicate (and the mean calculated) on a Nanodrop Spectropho-
tometer (Thermo Scientific) and its quality checked with an
Agilent Bioanalyzer. Only samples with an RNA Integrity
Number $6.5 were processed (most samples were .8).
1 mg of total RNA was reverse transcribed in a 20 ml final
volume using the High Capacity complementary DNA (cDNA)
Reverse Transcription kit with RNase inhibitor (Applied Biosys-
tems), according to the manufacturer’s instructions. A separate
microgram of total RNA was processed identically, but without
reverse transcriptase (Non-RT control). cDNA samples were then
diluted to 4 ng/ml using nuclease-free water (Sigma) and stored at
280uC.
Reverse transcription quantitative PCR (RT-qPCR) was
performed using an ABI Prism 7000 Sequence Detection System
(Applied Biosystems) using SYBR green reagents (Power SYBR
green, Applied Biosystems). All reactions were performed in
triplicate using 12.5 ml Power SYBR Green Master Mix, 300 nM
primers (forward and reverse), 20 ng (5 ml) of cDNA template and
nuclease-free water added to final volume of 25 ml. The reaction
cycle comprised an initial denaturation for 10 min at 95uC,
followed by 40 cycles of 95uC/15 sec; 60uC/60 sec. Threshold
cycle values (Ct values) were measured using the ABI SDS 3000
software (Applied Biosystems).
Primers were designed using Geneious Pro software (Biomatters
Inc) and NCBI sequence information (File S2). Primer specificity
was checked in silico using BLAST and in vitro using gel
electrophoresis and melt curve analysis. Primer efficiencies were
calculated according to the method described in Pfaffl (2001) [36];
all primer pairs had efficiency values of 1.9–2.1, which were used
in calculations of relative quantities of transcripts.
cDNA and non-RT control samples were probed for transcript
levels of FTO and 6 reference genes (File S2). Each sample was
processed in triplicate, for each primer set, and the average Ct
value was calculated. The Pfaffl method was used to transform Ct
values into relative quantities [36]. The geNorm applet for
Microsoft Excel was used to identify the 3 most stable reference
genes (Hspa8, Hmbs, and Rpl13a, in order of stability), and the
normalisation factor (the geometric mean; Vandesompele et al,
2001). The latter was then used to normalize the relative levels of
Fto. In a separate analysis, the stability of Fto relative to the
reference genes was assessed.
For RT-qPCR experiments, Ct values for Fto amplification were
significantly higher for non-RT controls (30.360.4 cycles, n=80)
than for cDNA samples (21.360.1 cycles, n=80; mean 6 SEM).
The minimum difference between non-RT controls and cDNA
samples was 3.1 cycles. Thus, contaminating genomic material
had negligible influence on the RT-qPCR results presented in this
paper.
Statistical analyses
ANOVA was used for all statistical analyses. Unless otherwise
stated, a two-way ANOVA was carried out in order to assess the
impact of both sex and feeding status, and a p value of ,0.05 was
considered statistically significant. Post-hoc pairwise comparisons
were made using the Bonferroni test to clarify the origin of
statistically significant results. Separate one-way ANOVAs were
used to determine the impact of the five different tissue types on
Fto mRNA and protein expression in free-fed animals. In addition,
a one-way ANOVA was used to compare the mean protein level
averaged across all brain regions to that averaged from both
muscles.
Supporting Information
Figure S1 Specificity of antibody raised against full-
length recombinant murine FTO. (A) Representative West-
ern blots. Lanes were loaded with total protein from rostral brain
(1), cerebellum (2), hypothalamus (3), gastrocnemius muscle (4),
extensor digitorum longus muscle (5) of free-fed (FF) and fasted
(Fast) mice. The same blot was probed with anti-FTO (left) and
anti-HSPA8 (right) antibodies (the blot was stripped after probing
with anti-FTO in order to visualise anti-HSPA8 staining). Both
antibodies detected a single band of the appropriate size: FTO was
approximately 60 kDa (predicted to be 58 kDa), and HSPA8 was
approximately 70 kDa (predicted to be 70 kDa). Blots are
representative of those obtained from more than 8 mice. Note
that the ‘empty’ lane that separates the brain from the muscle
samples contained a pre-stained protein size ladder, which does
not appear on the Western blot film. (B) Representative Western
blots of total protein from brain of wild-type mice (left lane), mice
lacking one copy of FTO (middle lane), and mice lacking both
copies of FTO (right lane). Above, anti-FTO antibody detected no
protein in mice lacking both copies of FTO. Below, beta-actin,
which acted as a loading control.
(TIFF)
Figure S2 DAB staining was specific for FTO antibody.
In the immunohistochemistry experiments, sections from each
brain were treated in the same way as experimental sections, but
no primary antibody was included in the first incubation step.
Representative images of these ‘no-primary-antibody’ control
sections from coronal sections of the cerebellum of a control (A)
and fasted (B) brain are shown. Brain sections from the same
control (C) and fasted (D) mice, processed with primary antibody
present, are also shown. Note that the control sections are devoid
of specific staining. Horizontal black bars indicate 200 mm.
(TIFF)
Figure S3 The widespread expression of FTO was not
altered by fasting. Sections were probed for FTO protein,
which was stained with DAB (black). Representative images of
sections from the hypothalamus (A), hippocampus and neocortex
(B), and cerebellum (C, D) of a fasted 7-week old female C57BL/
6J mice. 3V=3rd ventricle, CA1, CA3=subfields of hippocam-
pus, DG=dentate gyrus of hippocampus, I–VI=layers of
neocortex. Horizontal black bars indicate 200 mm. There were
no obvious differences in the pattern of FTO expression in the
brain compared with the fed state (Figure 1).
(TIFF)
Figure S4 The neuronal localisation of FTO was not
altered by fasting. Representative images of sections from the
hypothalamus (A), neocortex (B), cerebellum (C) and hippocampus
(D) of fasted 7-week-old male C57BL/6J mice. Sections were
probed for FTO protein (red) and the Neuronal Nuclear protein
(NeuN, green). DAPI was used to stain all nuclei (blue). The
majority (.90%) of cells in the hypothalamus and neocortex that
labelled with NeuN also labelled with FTO. Images are
representative of 5 mice. Horizontal grey bars represent 20 mm.
There were no obvious differences between images from fasted
and free-fed (Figure 3) mice.
(TIFF)
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PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e27968File S1 Stability of Fto mRNA levels in skeletal muscles
of free-fed and fasted mice. Fto and reference gene transcript
levels from 8 pairs of free-fed and fasted mice were analysed using
geNorm. The stability of the genes is arranged in ascending order
(left to right). (A) Data for rostral brain, cerebellum and
hypothalamus were analysed together and the stability of gene
expression is shown. (B) Data for gastrocnemius and extensor
digitorum longus muscle samples were analysed together and the
stability of gene expression is shown. In free-fed and fasted mice,
Fto itself was one of the most stably expressed genes. In the brain it
was at least fourth-most stable in each mouse. In skeletal muscles it
was the most stable gene in five of the eight pairs of mice.
(TIFF)
File S2 RT-qPCR primer information. Accession number,
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